|

Liver Cancer Clinical Trials in California

87 recruiting studies across 66 cities

Browse by City

All Trials in California

Phase
Trial Phase Location
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 2Arroyo Grande
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3Berkeley
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2Beverly Hills
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCPhase 2Beverly Hills
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2Cerritos
Observational Study Protocol: LIVER-R—Coronado
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerPhase 1Duarte
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer—Duarte
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesPhase 1Duarte
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsPhase 1/2Duarte
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3Duarte
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)Phase 1Duarte
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/2Duarte
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer—Duarte
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast CancerPhase 2Duarte
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant DiseasePhase 2Duarte
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases—Duarte
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCPhase 1/2Duarte
Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)—Duarte
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—Duarte
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Phase 1Duarte
Distance-Based Exercise to Preserve Function and Prevent DisabilityN/ADublin
Multi-analyte Blood Test Clinical Trial—Escondido
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment—Fountain Valley
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—Fullerton
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular CarcinomaPhase 1Glendale
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsPhase 1Irvine
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Phase 1/2Irvine
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE TrialPhase 1/2Irvine
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailurePhase 2Irvine
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2La Jolla
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3—La Jolla
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1La Jolla
BAL/BOT/agenT-797 in pMMR CRC With Liver MetastasesPhase 2La Jolla
CapTemY90 for Grade 2/3 NET Liver MetastasesPhase 2La Jolla
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/2La Jolla
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPhase 1La Jolla
Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or CancerN/ALa Jolla
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/ALong Beach
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver ImpairmentPhase 1Long Beach
A First in Human Study of PLT012 in Participants With Solid Tumor CancersPhase 1Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2Los Angeles
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 1Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsPhase 1Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Phase 1/2Los Angeles
CREO - Microwave Ablation Feasibility StudyN/ALos Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPhase 2Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsPhase 1Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaPhase 1/2Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1/2Los Angeles
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)N/ALos Angeles
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots—Los Angeles
National Liver Cancer Screening TrialPhase 4Los Angeles
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaPhase 1Los Angeles
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver MetastasesPhase 2Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesN/ALos Angeles
Early Detection of Advanced Adenomas and Colorectal Cancer—Monrovia
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular CarcinomaPhase 2Orange
Combination of TATE and PD-1 Inhibitor in Liver CancerPhase 2Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities—Orange
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic CancersN/AOrange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialPhase 2Orange
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialPhase 2Orange
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCCPhase 1/2Orange
TATE and Pembrolizumab (MK3475) in mCRC and NSCLCPhase 2Orange
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients—Palo Alto
Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerPhase 1/2Palo Alto
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology—Palo Alto
Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90—Palo Alto
REGULUS: MRI-guided Adaptive SABR for Liver CancersPhase 2Palo Alto
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2Palo Alto
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 1Palo Alto
The Vanguard Study: Testing a New Way to Screen for CancerN/APleasanton
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer—Redondo Beach
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic ImpairmentPhase 1Rialto
DESTINY-PANTUMOUR04—San Diego
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerPhase 1San Francisco
A Multicenter Cancer Biospecimen Collection Study—San Francisco
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1San Francisco
Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaPhase 2San Francisco
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular CarcinomaPhase 2San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersN/ASan Francisco
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant DiseasePhase 2Santa Monica
PSMA PET for the Staging and Management of Hepatocellular Carcinoma—West Los Angeles

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.